Evidence map›Paper›PMID 19765366›Full record

ArticleCurrent gastroenterology reports2009

Serotonin and the GI tract.

William L Hasler

Abstract read
PubMed Publisher
In one paragraph

Article in Current gastroenterology reports, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 51 citations in OpenAlex.

  1. Trial
  2. Article
  3. Gastroparesis: Myths, Misconceptions, and Management.Clinical and experimental gastroenterology · 2023
    Review
  4. Review
  5. Review
  6. Article
  7. Effect of Sleeve Gastrectomy on Bone Metabolism and Serum 5-Hydroxytryptamine in Obese Rats.Medical science monitor : international medical journal of experimental and clinical research · 2020
    Article
  8. Article
  9. Anti-inflammatory effects of alosetron mediated through 5-HTResearch in pharmaceutical sciences · 2019
    Article
  10. Review
  11. Indolethylamine-Frontiers in neuroscience · 2018
    Review
  12. Gastroparesis: Medical and Therapeutic Advances.Digestive diseases and sciences · 2017
    Review
  13. Symptomatic Improvement of Gastroparesis with Granisetron Transdermal System.Journal of neurogastroenterology and motility · 2016
    Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

William L HaslerDivision of Gastroenterology, University of Michigan Health System, Ann Arbor, MI 48109, USA. whasler@umich.edu
University of Michigan–Ann Arbor · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Serotonin (5-hydroxytryptamine, 5-HT) participates in several functions of the gastrointestinal tract. Receptors in seven families (5-HT(1)-5-HT(7)) were identified, many of which are present on enterocytes, intrinsic and extrinsic neurons, interstitial cells, and gut myocytes. Most 5-HT is released from enterochromaffin cells in response to physiologic and pathologic stimuli. Roles of 5-HT in health include control of normal gut motor activity, secretion, and sensation, and regulation of food intake and cell growth. Abnormalities of serotonergic function contribute to symptom genesis in functional bowel disorders, inflammatory and infectious diseases of the gut, emetic responses to varied stimuli, obesity, and dysregulation of cell growth. Therapies acting as agonists or antagonists of 5-HT receptors or that modulate 5-HT reuptake play prominent roles in managing these conditions, although use of many agents is hampered by cardiopulmonary complications. Novel agents are in testing, which may exhibit efficacy without significant toxicity.

Indexed as

AnimalsDrug Therapy, CombinationEnterocytesGastrointestinal AgentsGastrointestinal DiseasesGastrointestinal MotilityGastrointestinal TractHumansReceptors, SerotoninSerotoninSerotonin AgentsSerotonin AntagonistsSerotonin Receptor AgonistsTreatment OutcomeGastrointestinal AgentsReceptors, SerotoninSerotoninSerotonin AgentsSerotonin AntagonistsSerotonin Receptor Agonists

Identifiers

PMID19765366
OpenAlexW2089922699

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.